February 22, 2024

BioPharmGuyNews.png

Purchase Data

Promoted Listings

BIO is just around the corner!


We help brands create impactful connections at conferences and tradeshows. Leveraging technologies such as AR, VR, and everything in between, we craft immersive and captivating digital activations that complement your current strategy.


Our innovative approach not only deepens audience engagement, but also boosts booth traffic and amplifies brand visibility.


Visit us at clutchexperiential.com


Or contact our team to learn more!

BioPharmGuy

There are two ways to unsubscribe from this newsletter. One is the traditional route, whereby you click the proper link at the bottom of the email. A second, lesser-known method, is to email me directly, pointing out grammar, spelling or other trivial matters spotted in BioPharmGuy News 


Ok, I’m (partially) joking. But I don’t have an editor. My job is to maintain an amazing biotech company directory. Writing this is a secondary priority and I’m not going to spend additional hours every week perfecting it. 


Hope your ok, wiht that.


-BPG


Mailbag

“In the pharmaceutical world which is filled with black whites and grey, your newsletter brings colour and joy to my working life so thank you for the weekly smiles!”


Companies Added & Removed

29 companies added, 20 removed this week.


Best New Name:

Ziwig


Worst New Name:

Expert Systems


You Will Be Missed:

Theseus Pharmaceuticals


Excel summary file of adds/removals available free on our downloads page.

Industry

Iovance

FDA approved its first one-time cell therapy for a solid tumor. It showed a 31% response rate in advanced melanoma with 42% of responses lasting over two years.


Cell therapies have been all the rage for biotech companies the past decade and they show no sign of slowing down.


Plant-Inspired, Man

Numerous medicines have been derived from plants. That's true of many of the more familiar drugs such as aspirin and heroin. 


Thus, companies continue to do research on potential treatments obtained from the plant kingdom. MGC Pharmaceuticals is one of those and they sure do trumpet their focus on “plant-inspired medicine”.


Then you dig a little deeper and find out it’s one particular plant. And you probably know which one, duuuuuuude. 


We Got Bibs

Who doesn’t want to work at a company where you’re expected to go out to dinner once a month with the colleagues? 170 hours a month is simply not enough.


But wouldn’t it be even sweeter if, after the meetup, your boss posted a pic of the group all wearing bibs on the company website for the entire world to see? What glory.


Does the photographer regret the creepy “one-eyed selfie”?


Does Belgium have the narrowest dining tables in the world


So many questions.


Results Are In

In a vote tally that would make the most shameless democratic dictator blush, a shareholder proposal to oust and replace the board at YS Biopharma failed by a margin of 97,272,542 to ZERO.


Suck on that, Gurbanguly Berdimuhamedov and your lame 97.69% vote total in the 2017 Turkmenistan Presidential election. 


After the vote totals, the press release got even weirder, talking about a restraining order against a shadow board who lost this vote, intended to prevent them from masquerading as the legitimate board of the company.


Wild stuff.


Not Your Typical Biopharma

Canopus Biopharma, a public company out of Las Vegas, seems to have pivoted and is now doing business as “Blue Heaven Coffee”.


So, of course their product is…digital advertising technology?


What is even happening. How hard is it to rename a company??


Firefly Bio

New company out of South San Francisco working on antibody-drug conjugates. 


They have a good color scheme with unique options that mesh well together. More importantly, they have imagery that uses the antibody structure and turns it into a firefly.


That’s how you appease BioPharmGuy. Nice work. 8/10


Frostbite

FDA approved the first medicine for severe frostbite. Add us to the tally of folks who never would have thought this malady could have a drug-based solution.


The small clinical study showed 0/16 patients on this drug alone had amputation indicators after a week, whereas the patient population who received only other, unapproved treatments had 60% amputation indicators.


Some solid findings.


Trilobite

A Chinese company has launched a product called the Trilobite-100 Sequencer.


Why anyone would need to sequence a single trilobite, let alone 100 simultaneously is beyond us.


Big Paleontology must have more cash than we realized.

 

Watch Out, Drugs

In case you doubted this CEO's qualifications as a drug hunter, check out his baseball cap and be proven wrong, you hater.


Hope his drug hunt is more successful than that whole war on drugs, though.


Otherwise, drugs are about to go 2-for-2, like the US in World Wars.

Health & Science

Party Like It’s 1949

STDs are blowing up around America. None more so than syphilis. It’s up 80% from 2018-2022 and just hit rates not seen since the Truman administration. 


All this info is explained in a University of Washington article, which, as an added bonus, dropped a new woke euphemism on us:


“...persons who can become pregnant”


Then in the very next paragraph, the author describes congenital syphilis as:


“...when a mother with syphilis passes the infection to her fetus”. 


Tsk, tsk!


Don't they know 50% woke angers 100% of readers?

Promote Your Listing at BioPharmGuy

Check your website's analytics - BioPharmGuy was likely one of your top referrers for 2023.


Bump up those referrals even more with a Premium Listing. Read more about our Promoted Listings.

Subscribe!

If you're reading this and not a subscriber, please join our mailing list.

BioPharmGuy is a registered trademark of Wilsonian LLC, Content © 2023 Wilsonian LLC